The diverse distribution of these tau aggregates in the brain can potentially be useful in the differential diagnosis of these tauopathies, assuming the same tau imaging agent binds with similar affinity to the whole spectrum of tau aggregates. This evidence concerns the gene MAPT and tauopathy.